Boswellic acid – Medicinal use of an ancient herbal remedy

Abdel-Tawab, 2011, Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data, Clin. Pharmacokinet., 50, 349, 10.2165/11586800-000000000-00000 Agrawal, 2011, Antitumor properties of Boswellic acid against Ehrlich ascites cells bearing mouse, Food Chem. Toxicol., 49, 1924, 10.1016/j.fct.2011.04.007 Ahmadi, 2013, Potential applications of nanoshells in biomedical sciences, J. Drug Target Ali, 2011, Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats, Chin. Med., 6 Ammon, 1991, Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata, Planta Med., 57, 203, 10.1055/s-2006-960074 Ammon, 1993, Mechanism of antiinflammatory actions of curcumine and boswellic acids, J. Ethnopharmacol., 38, 113, 10.1016/0378-8741(93)90005-P Ammon, 1996, Salai Guggal – Boswellia serrata: from a herbal medicine to a non-redox inhibitor of leukotriene biosynthesis, Eur. J. Med. Res., 1, 369 Ammon, 1996, Salai Guggal – Boswellia serrata: from a herbal medicine to a specific inhibitor of leukotriene biosynthesis, Phytomedicine, 3, 67, 10.1016/S0944-7113(96)80012-2 Ammon, 2006, Boswellic acids in chronic inflammatory diseases, Planta Med., 72, 1100, 10.1055/s-2006-947227 Ammon, 2010, Modulation of the immune system by Boswellia serrata extracts and boswellic acids, Phytomedicine, 17, 862, 10.1016/j.phymed.2010.03.003 Anon, 1998, Boswellia serrata, Altern. Med. Rev., 3, 306 Bairwa, 2015, Development and optimisation of 3-acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats, J. Pharm. Pharmacol., 67, 1188, 10.1111/jphp.12420 Bonifacio, 2014, Nanotechnology-based drug delivery systems and herbal medicines: a review, Int. J. Nanomed., 9, 1 Buchele, 2003, Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection, J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 795, 355, 10.1016/S1570-0232(03)00555-5 Buchele, 2003, Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography Identification of lupeolic acid, a novel pentacyclic triterpene, J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci., 791, 21, 10.1016/S1570-0232(03)00160-0 Dohling, 2008, Boswellia serrata (Frankincense) – from traditional indian medicine (Ayurveda) to evidence-based medicine, Phytomedicine, 15, 540, 10.1016/j.phymed.2008.04.005 El-Khadem, 1972, Derivatives of boswellic acids, Planta Med., 22, 157, 10.1055/s-0028-1099599 Etzel, 1996, Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis, Phytomedicine, 3, 91, 10.1016/S0944-7113(96)80019-5 Glaser, 1999, Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity, Br. J. Cancer, 80, 756, 10.1038/sj.bjc.6690419 Goel, 2010, 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity, J. Pharm. Pharmacol., 62, 273, 10.1211/jpp.62.02.0016 Gupta, 2011, Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice, Int. Immunopharmacol., 11, 968, 10.1016/j.intimp.2011.02.011 Hoernlein, 1999, Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I, J. Pharmacol. Exp. Ther., 288, 613 Husch, 2013, Enhanced absorption of boswellic acids by a lecithin delivery form Phytosome® of Boswellia extract, Fitoterapia, 84, 89, 10.1016/j.fitote.2012.10.002 Indian Pharmacopoeia Commission, 2010, Monographs of herbs and herbal products, Kunduru, 2515 Jose, S. The Global Herbal Remedies Market. March 19 2012; available from: http://www.nutraceuticalsworld.com/issues/2012-04/view_market-research/the-global-herbal-remedies-market. (accessed 25.04.15.). Karima, 2012, An in vitro study of the role of beta-boswellic acid in the microtubule assembly dynamics, FEBS Lett., 586, 4132, 10.1016/j.febslet.2012.10.007 Khan, 2013, Dietary phytochemicals as potent chemotherapeutic agents against breast cancer: inhibition of NF-kappaB pathway via molecular interactions in rel homology domain of its precursor protein p105, Pharmacogn. Mag., 9, 51, 10.4103/0973-1296.108140 Kirste, 2011, Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial, Cancer, 117, 3788, 10.1002/cncr.25945 Kokkiripati, 2011, Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation, J. Ethnopharmacol., 137, 893, 10.1016/j.jep.2011.07.004 Kruger, 2008, Metabolism of boswellic acids in vitro and in vivo, Drug Metab. Dispos., 36, 1135, 10.1124/dmd.107.018424 Kumar, 2012, Acyl derivatives of boswellic acids as inhibitors of NF-kappaB and STATs, Bioorg. Med. Chem. Lett., 22, 431, 10.1016/j.bmcl.2011.10.112 Lalithakumari, 2006, Safety and toxicological evaluation of a novel, standardized 3-o-acetyl-11-keto-beta-boswellic acid (AKBA)-enriched boswellia serrata extract (5-Loxin®), Toxicol. Mech. Methods, 16, 199, 10.1080/15376520600620232 Leung, 1996 Madisch, 2007, Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial, Int. J. Colorectal Dis., 22, 1445, 10.1007/s00384-007-0364-1 Nandan, 2013, Therapeutic properties of boswellic acid nanoparticles in prostate tumor–bearing BALB/c mice model, J. Nanopharm. Drug Deliv., 1, 30, 10.1166/jnd.2013.1009 Olaku, 2011, Herbal therapy use by cancer patients: a literature review on case reports, Eur. J. Cancer, 47, 508, 10.1016/j.ejca.2010.11.018 Pang, 2009, Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis, Cancer Res., 69, 5893, 10.1158/0008-5472.CAN-09-0755 Paranjpe, 2001, Boswellia serrata, 233 Pardeshi, 2012, Solid lipid based nanocarriers: an overview, Acta Pharm., 62, 433, 10.2478/v10007-012-0040-z Raja, 2011, Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-beta-boswellic acid from Boswellia serrata, BMC Microbiol., 11 Reddy, 1989, Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents, Biochem. Pharmacol., 38, 3527, 10.1016/0006-2952(89)90124-X Reising, 2005, Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry, Anal. Chem., 77, 6640, 10.1021/ac0506478 Safayhi, 1995, Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid, Mol. Pharmacol., 47, 1212 Safayhi, 1997, Inhibition by boswellic acids of human leukocyte elastase, J. Pharmacol. Exp. Ther., 281, 460 Sanchez-Dominguez, 2014, Nanoparticles vs cancer: a multifuncional tool, Curr. Top. Med. Chem., 14, 664, 10.2174/1568026614666140118213316 Schweizer, 2000, Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues, J. Nat. Prod., 63, 1058, 10.1021/np000069k Sengupta, 2008, A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee, Arthritis Res. Ther., 10, R85, 10.1186/ar2461 Sharma, 2004, Pharmacokinetic study of 11-keto beta-boswellic acid, Phytomedicine, 11, 255, 10.1078/0944-7113-00290 Sharma, 2009, In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodents, Phytomedicine, 16, 1112, 10.1016/j.phymed.2009.06.009 Shehata, 2011, Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE), Phytomedicine, 18, 1037, 10.1016/j.phymed.2011.06.035 Siddiqui, 2011, Boswellia serrata, a potential antiinflammatory agent: an overview, Indian J. Pharm. Sci., 73, 255 Siemoneit, 2011, Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense, Br. J. Pharmacol., 162, 147, 10.1111/j.1476-5381.2010.01020.x Singh, 2007, Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis, Vascul. Pharmacol., 46, 333, 10.1016/j.vph.2006.09.008 Singh, 2008, The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats, Phytomedicine, 15, 408, 10.1016/j.phymed.2008.02.017 Singh, 2012, A-90 day gavage safety assessment of boswellia serrata in rats, Toxicol. Int., 19, 273, 10.4103/0971-6580.103668 1997 Sionneau, 1995 Skarke, 2012, Increased bioavailability of 11-keto-beta-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures, J. Clin. Pharmacol., 52, 1592, 10.1177/0091270011422811 Sterk, 2004, Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers, Planta Med., 70, 1155, 10.1055/s-2004-835844 Strappaghetti, 1982, Constituents of essential oil of Boswellia frereana, Phytochemistry, 21, 2114, 10.1016/0031-9422(82)83057-4 Tawab, 2001, Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma, J. Chromatogr. B Biomed. Sci. Appl., 761, 221, 10.1016/S0378-4347(01)00335-8 The Ayurvedic Pharmacopoeia of India, 2007 Vuddanda, 2010, Berberine: a potential phytochemical with multispectrum therapeutic activities, Expert Opin. Investig. Drugs, 19, 1297, 10.1517/13543784.2010.517745 Wichtl, 2004, Herbal drugs and phytopharmaceuticals: a handbook for practice on a scientific basis, Medpharm Wildfeuer, 1998, Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis, Arzneimittelforschung, 48, 668 Yang, 2002